Abbott’s FreeStyle Libre Flash Glucose Monitoring System, which assists diabetes patients retain inside the advisable glucose levels constantly without the need of pricking is now readily available in India. Continuous glucose monitoring assists diabetes retain their sugar levels in variety, which can be detrimental in stopping really serious complications. This ‘Time in Range’ is among 70 and 180 mg/dL and really should never ever be beyond this variety for much more than 75 minutes a day, as per suggestions for Indians.
Priced at Rs 5,500 for the monitor and Rs 5,000 for the single-use sensor which operates for two weeks, the Abbott’s FreeStyle Libre is perfect for Type 1 Diabetes patients for normal monitoring and for occasional monitoring in Type 2 patients. The sensor measures glucose just about every minute in interstitial fluid by means of a little (5.5mm lengthy) filament that is inserted just below the skin and held in location with a little adhesive pad.
Kalyan Sattaru, GM, Abbott’s diabetes care business enterprise, India, stated with the FreeStyle Libre reader diabetes patients can now verify the influence of their diet program, the path of glucose levels and glycemic index in true-time by just scanning the gadget more than the sensor and without the need of pricking your fingers.
“The Libre reader is a multifunctional device. Whatever data it has captured from the sensor over a period of eight hours, it actually analyses and puts it into some three, four very useful analytics, which helps the person with diabetes have an effective conversation with a doctor, even if it is over a telephone considering we are in the middle of a pandemic,” Sattaru explained. Abbott also has a Libre Pro model which is for user by health-related specialists only.
Earlier this year, the American Diabetes Association (ADA) had endorsed the use of Ambulatory Glucose Profile (AGP) or Time in Range (T1R) report to be integrated into the management of all forms of diabetes.
“While the traditional HbA1c is very useful in deciding the success in diabetes care, it is only an average of three months’ blood glucose values and does not give an idea on the direction of change of glucose or the duration which is spent in normal, high or low glucose levels,” explained Dr Jothydev Kesavadev. His Thiruvananthapuram-primarily based Jothydev’s Diabetes Research Centre had come up with the very first-ever analysis from India on T1R and its correlation with HbA1c. “The new reporting system will certainly help prevent the serious complications and death in a greater number of subjects with diabetes,” stated Dr Kesavadev.
Sattaru stated the reader shows the time in variety, as set by the wellness care specialists, as properly as the quantity of hypoglycaemic episodes. “The reader also functions as a blood glucose strip monitor and a blood keto strip monitor in addition to the sensor,” Sattaru stated. Since utilizing the sensor all then time can be an pricey proposition, the strip monitor can be employed in the intervals when the sensor is not getting employed. Plus, the readers also shows a digital logbook, an insulin dosage calculator and typical glucose levels for seven, 14, 30 and 90-day periods. “The reader stores the glucose values for up to 90 days, the sensor for eight hours,” he stated.
For now, Indian patients will be capable to see the information from the reader on the device only. Abbott is anticipated to launch its application to collate this information on intelligent devices in 2021. Sattaru stated they expedited the launch of Libre in India provided the pandemic and the comfort of managing diabetes remotely. Once the digital ecosystems are launched, he stated, “the sensor results can be directly loaded onto the mobile phone into the cloud, and can be viewed in real-time by the doctor or the caregiver of the person with diabetes”.
FreeStyle Libre has been advisable for use in Type 1 patients above 4 years and also for these with gestational diabetes. Sattaru explained that realtime monitoring is valuable for patients to fully grasp how their physique processes particular foods and use that information to handle their levels in the future. “This drives a behavioural change, whereby we have seen a HbA1C reduction of almost 1% and a reduction in hypoglycaemic events. We also seen an increase in time in rage which as a result has delayed hospitalisation.”
? The Indian Express .. Click here to join our channel (@indianexpress) and keep updated with the most recent headlines